|
|
TAN 21 HM 0471
|
BORTEPAN 3.5
|
Bortezomib 3.5 mg
|
panacea biotec pharma limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 24 HM 0351
|
BORTERO
|
Bortezomib 3.5 mg,Mannitol (Perlitol PF) 10 mg/0.05ml,Tertiary Butyl Alcohol 0.3 ml/ml,Water for injections Q.S to 1mL ml/ml
|
HETERO LABS LIMITED, UNIT - VI
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0246
|
BOSNIB 100
|
Bosutinib 100 mg/6 mL,Crospovidone (Polyplasdone XL Type A) 15.95 mg/6 mL,Dichlormethane Q.S mg/6 mL,Isopropyl Alcohol Q.S mg/6 mL,Magnesium Stearate 1.01 mg/6 mL,Microcrystalline Cellulose (PH 112) 18.61 mg/6 mL,Opadry Yellow 03F520242 4.35 mg/6 mL,Poloxamer 188 6.53 mg/6 mL,Povidone 2.90 mg/6 mL,Purified Water Q.S mg/6 mL
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 24 VM 0284
|
BOVICYCLINE 10%
|
Oxytetracycline Hydrochloride
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 VV 0488
|
BOVIVAC
|
Gurley media Eight components g/ml,Mycoplasma mycoides strain T1-44/2 10 X 7.0 /dose,Phosphate Buffer saline 1 ml ml,Skim Milk 4% g/ml
|
TANZANIA VACCINE INSTITUTE-TANZANIA VETERINARY LABORATORY.
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0150
|
BPROST
|
Bimatoprost 0.03 % w/v
|
BEXIMCO PHARMACEUTICALS LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 V 0327
|
BRAVECTO® Plus Solution
|
FLURALANER 112.5 mg,Moxidectin 5.6 mg
|
Intervet Production S.A
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0593
|
BRAVIFO 100
|
Acid citric anhydrous 0.5 mg/5.26ml,Dehydrated Alcohol 2.01 ml,Paclitaxel USP 100 mg/16.7 ml,Polyoxyl 35 Castor Oil 1.90 g/ml
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0594
|
BRAVIFO 300
|
Citric acid anhydrous 0.167 mg/5.26ml,Dehydrated Alcohol 0.672 ml,Paclitaxel USP 300 mg/50ml,Polyoxyl 35 Castor Oil 24.850 g/ml
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ 19 H 0132
|
BREATHEZY L (10/5)
|
Levocetirizine dihydrochloride 5 mg,Montelukast sodium equivalent to Montelukast 10 mg
|
MSN Laboratories Private Limited (Formulations Division)
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0253
|
BREATHIN
|
Sodium Chloride BP 0.65 % w/v
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0059
|
BRILIMANZ ODS 20
|
Ferric Oxide Yellow (Yellow Iron Oxide /Idacol Yellow Oxide of Iron/Sicovit Yellow 10) 0.400 mg/6 mL,Glycerol. 8.6 mg/6 mL,Hypromellose 5 cP (syn. Hydroxypropylmethylcellulose 2910) 38 mg/6 mL,Peppermint oil dementholised 2.0 mg/6 mL,Polysorbate-80 3.5 mg/6 mL,Propylene Gylcol 3.5 mg/6 mL,Purified Water Q.S. litres,Sodium lauryl sulfate. 2.00 mg/6 mL,Sucralose 2.00 mg/6 mL,Tadalafil 20 mg/6 mL
|
ZIM LABORATORIES LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0189
|
BRIMOPRESS EYE DROPS
|
Brimonidine Tartrate 0.2 % w/v
|
Centaur Pharmaceuticals Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0117
|
BRINZOX T
|
Brinzolamide 1.0 %w/v,Brinzolamide 10 mg/6 mL,Disodium Edetate 0.100 mg/6 mL,Mannitol to 33.000 mg/6 mL,Purified water.. q.s ml,Sodium Chloride BP. 1.00 mg/6 mL,Sodium Hydroxide, q.s ml,Timolol Maleate 0.5 %w/v,Tyloxapol 0.250 mg/6 mL,carbomer homopolymer Tybe B 974 P 4.00 mg/6 mL
|
Ajanta Pharma Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0268
|
BRIVANEXT 10
|
Anhydrous Lactose (Supertab 21 AN) 0.600 mg,Brivaracetam 10 mg,Croscarmellose Sodium (Ac-Di-sol). 2.000 mg,Lactose Monohydrate (Flowlac 100) 19.400 mg,Magnesium stearate (Ligamed MF 2V MB) USP-NF/Ph.Eur 0.600 mg,Opadry II White 85F580031 1.620 mg,Purified Water Q.S. NOT-SET,Silicified Microcrystalline Cellulose (Prosolv SMCC HD 90) 4.000 mg
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0057
|
BRIVANEXT 25
|
Anhydrous Lactose (Super Tab 21 AN) 45.000 mg,Brivaracetam 25 mg,Croscarmellose Sodium (Ac-Di-sol). 5.000 mg,Lactose Monohydrate (Flowlac 100) 48.500 mg,Magnesium stearate (Ligamed MF-2-V) 1.500 mg,Opadry II Pink 85F540289 4.050 mg,Purified Water Q.S. NOT-SET,Silicified Microcrystalline Cellulose (Prosolv SMCC HD 90) 10.000 mg
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0059
|
BRIVANEXT 50
|
Anhydrous Lactose (Super Tab 21 AN) 90.00 mg/6 mL,Brivaracetam 50 mg/6 mL,Croscarmellose Sodium (Ac-Di-Sol SD-711) USP-NF/Ph.Eur 10.00 mg/6 mL,Lactose Monohydrate (Flowlac 100) 97.00 mg/6 mL,Magnesium stearate (Ligamed MF 2V MB) USP-NF/Ph.Eur 3 mg/6 mL,Opadry II Yellow 85F92209 8.100 mg/6 mL,Purified water.. QS litres,Silicified Microcrystalline Cellulose (Prosolv SMCC 90) 20 mg/6 mL
|
MSN Laboratories Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0584
|
BRIVON
|
Benzalkonium Chloride Solution 50% w/v 0.2 micro litre,Brimonidine Tartrate 0.2 %w/v,Disodium Edetate 0.2 mg/ml,Disodium Hydrogen Phosphate Dihydrate 11.9 mg/ml,Hydrochloric acid --- mg/ml,Sodium Dihydrogen Phosphate Dihyrate 5.2 mg/ml,Water for Injection --- mg/ml
|
ATCO Laboratories Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 HM 0582
|
BRIVON-T
|
Benzalkonium Chloride Solution 50% w/v 0.2 micro litre,Brimonidine Tartrate 0.2 %w/v,Disodium Edetate 0.2 mg/ml,Disodium Hydrogen Phosphate Dihydrate 11.9 mg/ml,Sodium dihydrogen phosphate dehydrate 5.2 mg/ml,Timolol Maleate Equivalent to Timolol 0.5 %w/v,Water for Injection --- mg/ml
|
ATCO Laboratories Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0282
|
BRIZAGAN
|
Benzalkonium chloride 0.05 mg/5.26ml,Brimonidine Tartrate 2 mg/5.26ml,Citric Acid Monohydrate 0.50 mg/5.26ml,Polyvinyl Alcohol 14.00 mg/5.26ml,Sodium Chloride 7.00 mg/5.26ml,Sodium Citrate Dihydrate 4.50 mg/5.26ml,Sodium Hydroxide Solution 1N Q.S. to pH 6.1 mg/5.26ml,Water for Injection Q.S. to 1ml ml/ml
|
RAFARM SA
|
Registered/Compliant
|
Details →
|